Excess Factor VIII: A Common Cause of Hypercoagulability

References

1. ↵
   Locke CF and Evans NC. Evaluating idiopathic venous thromboembolism: what is necessary, what is not. J Fam Pract 2003; 52: 770–6.

   OpenUrlPubMed
2. ↵
   Ridker PM, Militich JP, Hennekens CH, Buring JE. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA 1997; 277: 1305–7.

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995; 345: 152–5.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   Kraaijenhagen RA, in’t Anker PS, Koopman MM, et al. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost 2000; 83: 5–9.

   OpenUrlPubMedWeb of Science
5. ↵
   Kyrle PA, Minar E, Hirschl M, et al. High plasma levels of factor VIII and risk of recurrent thromboembolism. N Engl J Med 2000; 343: 457–62.

   OpenUrlCrossRefPubMedWeb of Science
6. ↵
   O’Donnell J, Mumford AD, Manning RA, Laffan M. Elevation of FVIII: C in venous thromboembolism is persistent and independent of the acute phase reaction. Thromb Haemost 2000; 83: 10–3.

   OpenUrlPubMedWeb of Science
7. O’Donnell J, Tuddenham EG, Manning R, Kemball-Cook G, Johnson D, Laffan M. High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction. Thromb Haemost 1997; 77: 825–8.

   OpenUrlPubMedWeb of Science
8. ↵
   Kamphuisen PW, Eikenboom JC, Vos HL, et al. Increased levels of factor VIII and fibrinogen in patients with venous thromboembolism are not caused by acute phase reactions. Thromb Haemost 1999; 81: 680–3.

   OpenUrlPubMedWeb of Science
9. ↵
   Asherson RA. Antiphospholipid antibodies and syndromes. In: Systemic lupus erythematosus, 2nd ed (Lahita RG, editor). New York: Churchill Livingstone; 1992. p. 587–635.
10. ↵
    Levine JS, Branch DW, Rauch J. Antiphospholipid antibody syndrome. N Engl J Med 2002; 346: 752–63.

    OpenUrl
11. ↵
    Kim V, Spandorfer J. Epidemiology of venous thromboembolic disease. Emerg Med Clin North Am 2001; 19: 839–59.

    OpenUrlCrossRefPubMed
12. ↵
    Goldenberg NA, Knapp-Clevenger R, Manco-Johnson MJ. Elevated plasma factor VIII and d-dimer levels as predictors of poor outcomes of thrombosis in children. N Engl J Med 2004; 351: 1081–8.

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    Ridker PM. Inherited risk factors for venous thromboembolism: implications for clinical practice. Clin Cornerstone 2002; 4: 18–30.

    OpenUrlPubMed